Abstract
Research Overview
In the late 1990s, the U.S. vitamin C market was plagued by allegations of
vitamin cartels and price fixing. The market has since recovered, but pricing
pressures continue to puch European manufacturers out of the business.
Companies such as DSM Nutritional Products and BASF Corporation feel the price
pressures from Chinese manufacturers whose vitamin C products cost less to
produce due to lower labor and raw material costs. These two companies have
eliminated their U.S. production capabilities and are now narrowing their
focus to existing European facilities. These cuts have reduced their
manufacturing capabilities by 50 percent.
This research service address the U.S. vitamin C market from five angles by
providing drivers, restraints, forecasts, trends, and application analysis at
the overall market level and application levels. The vitamin C market was
monopolized by seven key manufacturers and generated $151.7 million in
revenues in 2005. The four main applications of vitamin C in the U.S. market
are for cosmetic formulations, dietary supplements, animal feed fortification,
and food and beverages.